3.Cerebrospinal fluid adenosine deaminase activity for the diagnosis of tuberculous meningitis
Qin SUN ; Wei SHA ; Heping XIAO ; Qing TIAN ; Hong ZHU
Chinese Journal of Clinical Infectious Diseases 2010;03(5):263-266
Objective To evaluate cerebrospinal fluid adenosine deaminase(CSF-ADA)activity in the diagnosis of tuberculous meningitis(TMB), and to observe its dynamic changes. Methods A total of 160 patients were included and were divided into two groups: 76 cases of TBM and 84 cases of non-TBM.Among the cases of non-TBM, there were 36 cases of bacterial meningitis, 30 cases of viral meningitis and 18 cases of cryptocoocal meningitis. All the patients were measured with their CSF-ADA activity by Enzymecoupled assay(Trinder method)and 47 patients of TBM were measured again after 2 weeks' and 6 weeks'antitubercular therapy. Results were expressed as(-x)± s. Mann-Whitney U test and paired-samples t test were used. Results CSF-ADA activity in TBM group was(12.9 ±6.4)U/L, while that in the non-TBM group was(6.0 ± 4.1)U/L, the difference was of statistical significance(U = 7.860, P < 0.05). With the cutoff value of 9 U/L, the sensitivity and specificity to differentiate TBM from non-TBM was 84.21% and 83. 33%, respectively. CSF-ADA activity decreased in TBM patients after antitubercular treatment.Conclusions CSF-ADA activity can be an effective laboratory marker for early differential diagnosis of TMB with the cut-off value of 9 U/L. Dynamic changes of CSF-ADA activity may be a indicator for the effect of antitubercular treatment.
5.Updated treatments of castration-resistant prostate cancer.
Yun-fei WEI ; Xiao-jian GU ; Qing-yi ZHU
National Journal of Andrology 2016;22(5):455-461
The diagnosis and treatment of prostate cancer are being improved due to the popularized screening of prostate specific antigen. Advanced prostate cancer, in spite of its response to androgen deprivation therapy, may finally develop into castration-resistant prostate cancer (CRPC) and shorten the overall survival of the patients. Many efforts have been made by worldwide researchers for new approaches to the management of CRPC, including new hormonal therapy, cytotoxic chemotherapy, immunotherapy, and bone metastasis-targeted therapy. This paper reviews the emerging agents undergoing clinical evaluation and drugs that have received approval for the treatment of CRPC in order to provide doctors and patients with more treatment options for CRPC and improve the overall survival rate and quality of life of the patients.
Androgen Antagonists
;
Bone Neoplasms
;
prevention & control
;
Humans
;
Immunotherapy
;
Male
;
Prostate-Specific Antigen
;
blood
;
Prostatic Neoplasms, Castration-Resistant
;
therapy
;
Quality of Life
6.Clinicopathologic characteristics of intestinal T-cell lymphoma
qing, WEI ; xiao-long, JIN ; yan-bo, ZHU ; ping, YUAN
Journal of Shanghai Jiaotong University(Medical Science) 2006;0(05):-
Objective To study the clinicopathologic characteristics and differential diagnosis of T-cell immunophenotype in intestinal non-Hodgkin's lymphoma(NHL).Methods The clinicopathologic characteristics of 13 cases with intestinal T-cell lymphoma were analyzed by light microscopy and immunohistochemistry(Envision detection method).Results The lesions of 8 cases with T-cell lymphoma were found on the small intestine and 5 on the colon.Grossly,8 cases showed ulcer pattern,3 polypoid pattern and 2 presented as a regional thickening of intestinal wall.The tumor cells were medium to large size with pleomorphic nuclei and inflammatory background.The neoplastic lesions expressed the immunophenotype of peripheral T cells.The neoplastic cells of 13 cases(100%)expressed leukocyte common antigen(LCA);10(76.9%)cases expressed CD3;9(69.2%)CD45RO;5(38.5%)EB virus(EBV);3(23.1%)CD56 and 2(15.4%)vimentin(VIM).All the cases were negative for CD20,CD79a,CK,CDX2,NSE,CgA and CD117.ConclusionIntestinal T-cell lymphoma is a rare,aggressive neoplasm with poor prognosis and should be distinguished from other malignant tumors of intestine.
8.HIV mucosal infection and research development of its blocking biological technique.
Su-Gan QIU ; Jian-Qing ZHU ; Xiao-Yan ZHANG
Chinese Journal of Virology 2010;26(6):500-503
Animals
;
Anti-HIV Agents
;
pharmacology
;
HIV
;
drug effects
;
genetics
;
physiology
;
HIV Infections
;
drug therapy
;
immunology
;
virology
;
Humans
;
Mucous Membrane
;
immunology
;
virology
;
Virus Replication
;
drug effects
9.A mucosal immune cells homing and infection of HIV.
Liang-zhu LI ; Jian-qing XU ; Xiao-yan ZHANG
Chinese Journal of Virology 2010;26(3):260-264
10.Advances in Brainstem Infarction
Dan ZHU ; Chun-Xiao YANG ; Qing-Cheng LIANG ;
International Journal of Cerebrovascular Diseases 2006;0(11):-
Brainstem infarction accounts for about 9% to 21.9% of all cerebral infarctions. This article reviews the etiology of brainstem infarction and its pathogenesis,clinical manifestation,diagnosis,and treatment.